Multiple sclerosis (MS) is a disease for which no cure has yet been found. Its progression may be delayed thanks to new drugs, but the active ingredients in those drugs are either only partially effective or may lead to severe side effects.
Recent developments in the field of dermatology have given rise to hope. Researchers in Bochum have discovered that MS symptoms are considerably alleviated through the application of an active pharmaceutical ingredient on the basis of fumaric acid that has long been successfully used against psoriasis.
Patients suffered 50% fewer flare-ups and the number of active inflammatory foci was reduced by up to 90%. Researchers have now discovered in what way fumaric acid esters protect nerve cells. Their report has been published in the international edition of RUBIN, the science magazine issued by the Ruhr University Bochum.
MS: Most common neurological cause of disabilities in young adults.Multiple sclerosis is the most common neurological cause of disabilities in young adults. In Germany, it currently affects some 130,000 patients. In MS patients, the body’s own immune system attacks the nerve fibres’ “insulating layer” and destroys it. Typically, all regions of the brain and the spinal cord are affected as the disease progresses. The inflammations result in ataxia, impairment of fine motor skills, as well as concentration loss, bladder function impairment, fatigue and depressive episodes.
Dr. Josef König | idw
Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University
The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
02.12.2016 | Medical Engineering
02.12.2016 | Agricultural and Forestry Science
02.12.2016 | Physics and Astronomy